Namiranian S, Naito Y, Kakkar V V, Scully M F
Thrombosis Research Institute, London, U.K.
Biochem J. 1995 Aug 1;309 ( Pt 3)(Pt 3):977-82. doi: 10.1042/bj3090977.
The ability of U937 monocyte-like cells and KATO III cells (a human gastric carcinoma line) to potentiate activation of plasminogen by single-chain urokinase-type plasminogen activator (scu-PA), as mediated by the cell receptor for urokinase (u-PAR), was compared. It was observed that, although the concentration of u-PAR on these cell lines differed considerably (U937 cells: 5000 receptors/cell, Kd 0.35 nM; KATO III cells: 400 receptors/cell, Kd 0.85 nM), the rate of activation of plasminogen by scu-PA in the presence of the same density of each cell line was equivalent. From data generated in the presence of increasing concentrations of scu-PA, the kcat, for plasminogen activation in the presence of each cell line was calculated and found to differ by 26-fold (0.36 s-1 on U937 cells; 9.25 s-1 on KATO III cells). However, the Km for plasminogen with respect to the rate of formation of plasmin was lower than the Kd for binding (0.2 microM compared with 0.5 microM on U937 cells; 0.34 microM compared with 1.6 microM on KATO III cells). A rapid transformation from Glu-plasminogen (native plasminogen with N-terminal Glu) to Lys-plasminogen (plasmin-degraded plasminogen with primarily N-terminal Lys-77) occurred on the surface of U937 cells (unlike KATO III cells), but this transition did not coincide with faster rates of plasminogen activation. From this evidence it is concluded that the accessibility of bound plasminogen acts to limit the rate of activation by cell-bound urokinase. The significance of this proposal is that the proteolytic potential of the cell-mediated activation of plasminogen would be controlled by the accessibility of plasminogen for activation rather than by the concentration of u-PAR (the latter may act to localize proteolysis to appropriate domains on the surface of the cell).
比较了U937单核细胞样细胞和KATO III细胞(一种人胃癌细胞系)通过单链尿激酶型纤溶酶原激活剂(scu-PA)增强纤溶酶原激活的能力,该激活作用由尿激酶细胞受体(u-PAR)介导。观察到,尽管这些细胞系上u-PAR的浓度差异很大(U937细胞:5000个受体/细胞,Kd为0.35 nM;KATO III细胞:400个受体/细胞,Kd为0.85 nM),但在每种细胞系密度相同的情况下,scu-PA激活纤溶酶原的速率是相当的。根据在scu-PA浓度增加时产生的数据,计算了在每种细胞系存在下纤溶酶原激活的kcat,发现相差26倍(在U937细胞上为0.36 s-1;在KATO III细胞上为9.25 s-1)。然而,相对于纤溶酶形成速率的纤溶酶原Km低于结合的Kd(在U937细胞上分别为0.2 microM和0.5 microM;在KATO III细胞上分别为0.34 microM和1.6 microM)。在U937细胞表面(与KATO III细胞不同)发生了从Glu-纤溶酶原(具有N端Glu的天然纤溶酶原)到Lys-纤溶酶原(主要具有N端Lys-77的纤溶酶降解的纤溶酶原)的快速转变,但这种转变与更快的纤溶酶原激活速率并不一致。根据这些证据得出结论,结合的纤溶酶原的可及性限制了细胞结合的尿激酶的激活速率。该提议的意义在于,细胞介导的纤溶酶原激活的蛋白水解潜力将由纤溶酶原激活的可及性控制,而不是由u-PAR的浓度控制(后者可能起到将蛋白水解定位到细胞表面适当区域的作用)。